LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA–target regulations in human diseases
Nucleic Acids Research · 06.01.2023 · 51 (D1) · D199-D207
DOI: 10.1093/nar/gkac984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 02.11.2022. Verfasst von Hongying Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China. Hauptthemen laut MEDLINE: Databases, Nucleic Acid, RNA, Long Noncoding. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University Nursing Program for Young Scholar with Creative Talents in Heilongjiang Province, Excellent Youth Project of Provincial scientific research Institute, Hei Long Jiang Postdoctoral Special Foundation.
Abstract (Originalsprache)
An updated LncTarD 2.0 database provides a comprehensive resource on key lncRNA–target regulations, their influenced functions and lncRNA-mediated regulatory mechanisms in human diseases. LncTarD 2.0 is freely available at (http://bio-bigdata.hrbmu.edu.cn/LncTarD or https://lnctard.bio-database.com/). LncTarD 2.0 was updated with several new features, including (i) an increased number of disease-associated lncRNA entries, where the current release provides 8360 key lncRNA–target regulations, with 419 disease subtypes and 1355 lncRNAs; (ii) predicted 3312 out of 8360 lncRNA–target regulations as potential diagnostic or therapeutic biomarkers in circulating tumor cells (CTCs); (iii) addition of 536 new, experimentally supported lncRNA–target regulations that modulate properties of cancer stem cells; (iv) addition of an experimentally supported clinical application section of 2894 lncRNA–target regulations for potential clinical application. Importantly, LncTarD 2.0 provides RNA-seq/microarray and single-cell web tools for customizable analysis and visualization of lncRNA–target regulations in diseases. RNA-seq/microarray web tool was used to mining lncRNA–target regulations in both disease tissue samples and CTCs blood samples. The single-cell web tools provide single-cell lncRNA–target annotation from the perspectives of pan-cancer analysis and cancer-specific analysis at the single-cell level. LncTarD 2.0 will be a useful resource and mining tool for the investigation of the functions and mechanisms of lncRNA deregulation in human disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
ORCID-Profile: Shangwei Ning, Li Wang
Förderung
- University Nursing Program for Young Scholar with Creative Talents in Heilongjiang Province
- Excellent Youth Project of Provincial scientific research Institute
- Hei Long Jiang Postdoctoral Special Foundation
Zitieren
APA
Zhao, H., Yin, X., Xu, H., Liu, K., Liu, W., Wang, L., Zhang, C., Bo, L., Lan, X., Lin, S., Feng, K., Ning, S., Zhang, Y., & Wang, L. (2023). LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA–target regulations in human diseases. Nucleic Acids Research, 51(D1), D199-D207. https://doi.org/10.1093/nar/gkac984
Vancouver
Zhao H, Yin X, Xu H, Liu K, Liu W, Wang L, et al. LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA–target regulations in human diseases. Nucleic Acids Research. 2023;51(D1):D199-D207. doi:10.1093/nar/gkac984
BibTeX
@article{Zhao2023,
author = {Zhao, Hongying and Yin, Xiangzhe and Xu, Haotian and Liu, Kailai and Liu, Wangyang and Wang, Lixia and Zhang, Caiyu and Bo, Lin and Lan, Xicheng and Lin, Shihua and Feng, Ke and Ning, Shangwei and Zhang, Yunpeng and Wang, Li},
title = {LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA–target regulations in human diseases},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {D1},
pages = {D199--D207},
doi = {10.1093/nar/gkac984}
}
EUVIMED